Suffolk Capital Management’s Pfizer PFE Stock Holding History

Suffolk Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$259K	Sell	6,263 -3,125	-33%	-$130K	0.05%	111
2018 Q3	$393K	Buy	+9,388	New	+$361K	0.06%	114
2016 Q2	–	Sell	-336,578	Closed	-$9.46M	–	155
2016 Q1	$9.46M	Sell	336,578 -71,636	-18%	-$2.05M	1.26%	31
2015 Q4	$12.5M	Buy	408,214 +381,427	+1,424%	+$12M	1.59%	19
2015 Q3	$798K	Sell	26,787 -28	-0.1%	-$898	0.11%	131
2015 Q2	$853K	Buy	26,815 +1,956	+8%	+$63.7K	0.1%	130
2015 Q1	$821K	Buy	24,859 +17,918	+258%	+$570K	0.1%	133
2014 Q4	$205K	Buy	+6,941	New	+$199K	0.03%	133
2014 Q3	–	Sell	-161,894	Closed	-$4.56M	–	155
2014 Q2	$4.56M	Buy	+161,894	New	+$4.61M	0.55%	59
2014 Q1	–	Sell	-310,424	Closed	-$9.02M	–	152
2013 Q4	$9.02M	Buy	310,424 +101,079	+48%	+$2.94M	1.13%	38
2013 Q3	$5.71M	Buy	+209,345	New	+$5.7M	0.77%	46

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Suffolk Capital Management's PFE Position: Q4 2018 in Review

Suffolk Capital Management reduced its Pfizer (PFE) stake by 33% in Q4 2018, selling an estimated $130K and leaving 6,263 shares worth $259K. The position accounts for 0.05% of the portfolio, ranked #111.

Suffolk Capital Management first reported a position in PFE in Q3 2013 and has held it in 11 quarters since. The position peaked at $12.5M in Q4 2015. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Suffolk Capital Management held 6,263 shares of Pfizer worth $259K as of Q4 2018.
Suffolk Capital Management sold 3,125 Pfizer shares in Q4 2018, an estimated $130K.
Pfizer made up 0.05% of Suffolk Capital Management's portfolio in Q4 2018, its #111 holding.
Suffolk Capital Management first reported a position in Pfizer in Q3 2013 and has held it in 11 quarters since.
Suffolk Capital Management's Pfizer position peaked at $12.5M in Q4 2015.
2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.